Last reviewed · How we verify

Experimental Denture Adhesive

GlaxoSmithKline · Phase 3 active Small molecule

A denture adhesive formulation that enhances the mechanical retention and seal of dentures to oral tissues.

A denture adhesive formulation that enhances the mechanical retention and seal of dentures to oral tissues. Used for Denture retention and stability in edentulous patients.

At a glance

Generic nameExperimental Denture Adhesive
SponsorGlaxoSmithKline
ModalitySmall molecule
Therapeutic areaDental/Oral Health
PhasePhase 3

Mechanism of action

Denture adhesives work by creating a physical and chemical bond between the denture base and the underlying oral mucosa, improving retention, stability, and comfort during mastication and speech. This experimental formulation from GSK likely incorporates novel polymeric or adhesive components designed to improve biocompatibility, duration of hold, or ease of removal compared to existing products.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: